Involvement of nitric oxide in nicotinic receptor-mediated myopathy

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 3, 1997, Pages 1463-1470

  El Dada, Manar D ^a   Quik, Maryka ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b PARKINSON S INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; BUNGAROTOXIN; NICOTINIC RECEPTOR; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SYNTHESIS; HIPPOCAMPUS; MUSCLE ATROPHY; MYENTERIC PLEXUS; MYOPATHY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART DISEASES; NICOTINE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 0031010470     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. ARIENS, A. T., MEETER, E., WOLTHUIS, O. L. AND VAN BENTHUM, R. M. J.: Reversible necrosis at the end-plate region in striated muscles of the rate poisoned with cholinesterase inhibitors. Experientia 25: 57-59, 1969.
2. BRAUN, S., TRANCHANT, C., VILQUIN, J. T., LABOURET, P., WARTER, J. M. AND POINDRON, P.: Stimulating effect of prednisolone on acetylcholine receptor expression and myogenesis in primary culture of newborn rat muscle. J. Neurol. Sci. 92: 119-131, 1989.
3. BRENMAN, J. E., CHAO, D. S., XIA, H., ALDAPE, K. AND BREDT, D. S.: Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in duchenne muscular dystrophy. Cell 82: 743-752, 1995.
4. BRENMAN, J. E., CHAO, D. S., GEE, S. H., MCGEE, A. W., CRAVEN, S. E., SANTILLANO, D. R., WU, Z., HUANG, F., XIA, H., PETERS, M. F., FROEHNER, S. C. AND BREDT, D.: Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PDZ domains. Cell 84: 757-767, 1996.
5. BRIGGS, C. A.: Potentiation of nicotinic transmission in the rate superior cervical sympathetic ganglion: Effects of cyclic GMP and nitric oxide generators. Brain Res. 573: 139-146, 1992.
6. CHAPMAN, P. F., ATKINS, C. M., ALLENS, M. T. HALEY, J. E. AND STEINMETZ, J. E.: Inhibition of nitric oxide synthesis impairs two different forms of learning. Neuroreport 3: 567-570, 1992.
7. CHOI, D. W.: Cerebral hypoxia: Some new approaches and unanswered questions. J. Neurosci. 10: 2493-2501, 1990.
8. DALAKAS, M. C.: Retrovirus-related muscle diseases. In Myology, 2nd ed., ed. by A. G. Engel and C. Franzini-Armstrong, pp. 1419-11437, McGraw-Hill, New York, 1994.
9. DAWSON, T. M., DAWSON, V. L. AND SNYDER, S. H.: A novel neuronal messenger molecular in brain: The free radical, nitric oxide. Ann. Neurol. 32: 297-311, 1992.
10. DAWSON, V. L.: Nitric oxide: Role in neurotoxicity. Clin. Exp. Pharmacol. Physiol. 22: 305-308, 1995.
11. DAWSON, V. L., DAWSON, T. M., LONDON, E. D., BREDT, S. H. AND SNYDER, S. H.: Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U.S.A. 88: 6368-6371, 1991.
12. DECKER, E. R. AND DANI, J. A.: Calcium permeability of the nicotinic acetylcholine receptor: The single-channel calcium influx is significant. J. Neurosci. 10: 3413-3420, 1990.
13. DINERMAN, J. L., DAWSON, T. M., SCHELL, M. J., SNOWMAN, A. AND SNYDER, S. H.: Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: Implications for synaptic plasticity. Proc. Natl. Acad. Sci. U.S.A. 91: 4214-4218, 1994.
14. ENGEL, A. G., LAMBERT, E. H. AND SANTA, T.: Study of long-term anticholinesterase therapy; effects on neuromuscular transmission and on motor endplate fine structure. Neurology 23: 1273-1281, 1973.
15. ENGEL, A. G., HOHFELD, R. AND BANKER, B. Q.: The polymyositis and dermatomyositis syndromes. In Myology, 2nd ed., ed. by A. G. Engel, and C. Franzini-Armstrong, pp. 1335-1383, McGraw-Hill, New York, 1994.
16. FENICHEL, G. M., KIBLER, W. B., OLSON, W. H. AND DETTBARN, M. D.: Chronic inhibition of cholinesterase as a cause of myopathy. Neurology 22: 1026-1032, 1972.
17. FREEMAN, S. S., ENGEL, A. G. AND DRACHMAN, D. B.: Experimental acetylcholine blockade of the neuromuscular junction: Effect on endplate and muscle fiber ultrastructure. Ann. N.Y. Acad. Sci. 274: 46-60, 1976.
18. GARTHWAITE, J. AND BOULTON, C. L.: NITRIC OXIDE SIGNALLING IN THE CENTRAL NERVOUS SYSTEM. ANN. REV. PHYSIOL. 57: 683-706, 1995.
19. HUANG, P. L., DAWSON, T. M., BREDT, D. S., SNYDER, S. H. AND FISHMAN, M. C.: Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75: 1273-1286, 1993.
20. HUDSON, C. S., RASH, J. E., TIEDT, T. N. AND ALBUQUERQUE, E. X.: Neostigmine induced alterations at the mammalian neuromuscular junction ultrastructure. II. J. Pharmacol. Exp. Ther. 205-356, 1978.
21. KAPLAN, I., BLAKELY, B. T., PAVLATH, G. K., TRAVIS, M. AND B. H. M.: Steroids induced acetylcholine receptors on cultured human muscle: Implications for myasthenia gravis. Proc. Natl. Acad. Sci. U.S.A. 87: 8100-8104, 1990.
22. KING, C. E., MELINYSHYN, M., MEWBURN, J., CURTIS, S., WINN, M., CAIN, S. AND CHAPLER, C.: Canine hindlimb blood flow and oxygen uptake after inhibition of EDRF/NO synthesis. J. Appl. Physiol. 76: 1166-1171, 1994.
23. KOBZIK, L., REID, M. B., BREDT, D. S. AND STAMLER, J. S.: Nitric oxide in skeletal muscle. Nature (Lond.) 372: 546-548, 1994.
24. KOBZIK, L., STRINGER, B., BALLINGER, J-L., REID, M. B. AND STAMLER, J. S.: Endothelial type nitric oxide in skeletal muscle fibers: Mitochondrial relationships. Biochem. Biophys. Res. Commun. 211: 375-381, 1995.
25. LEONARD, J. P. AND SALPETER, M. M.: Agonist induced myopathy at the neuromuscular junction is mediated by calcium. J. Cell Biol. 82: 811-819, 1979.
26. LEONARD, J. P. AND SALPETER, M. M.: Calcium mediated myopathy at the neuromuscular junction of normal and dystrophic muscle. Exp. Neural. 76: 121-138, 1982.
27. LIN, Y. Q. AND BENNETT, M. R.: Nitric oxide modulation of quantal secretion in chick ciliary ganglion. J. Physiol. 481: 385-394, 1994.
28. LOWENSTEIN, C. J., DINERMAN, J. L. AND SNYDER, S. H.: Nitric oxide: A physiologic messenger. Ann. Intern. Med. 120: 227-237, 1994.
29. MACMICKING, J. D., NATHAN, C., HOM, G., CHARTRAIN, N., FLETCHER, D., TRUMBAUER, M., STEVENS, K., XIE, Q-W., SOKOL, K., HUTCHINSON, N., CHEN, H. AND MUDGETT, J. S.: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641-650, 1995.
30. MATTSON, M. P.: Neurotransmitters in the regulation of neuronal cytoarchitecture. Brain Res. Rev. 13: 179-212, 1989.
31. MELDRUM, B. AND GARTHWAITE, J.: Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11: 379-387, 1990.
32. MONCADA, S., PALMER, R. M. J. AND HIGGS, E. A.: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
33. MULSCH, A., LUCKHOFF, L., POHL, U., BUSSE, R. AND BASSENGE, E.: LY83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator induced cyclic GMP increases and inhibition of platelet activation. Naunyn-Schmiedeberg's Arch. Pharmacol. 340: 119-1125, 1989.
34. NAKANE, M., SCHMIDT, H. W., POLLOCK, J. S., FORSTERMANN, U. AND MURAD, F.: Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett. 316: 175-180, 1993.
35. NESTLER, E. J., BEAM, K. G. AND GREENGARD, P.: Nicotinic cholinergic stimulation increases cyclic GMP levels in vertebrate skeletal muscle. Nature (Lond.) 275: 451-453, 1978.
36. NOWICKI, J. P., DUVAL, D., POIGNET, H. AND SCATTON, B.: Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur. J. Pharmacol. 204: 339-340, 1991.
37. O'DELL, T. J., HUANG, P. L., DAWSON, T. M., DINERMAN, J. L., SNYDER, S. H., KANDEL, E. R. AND FISHMAN, M. C.: Endothelial NOS and the blockade by NOS inhibitors in mice lacking neuronal NOS. Science (Wash. DC) 265: 542-546, 1994.
38. PRZEDBORSKI, S., JACKSON-LEWIS, V., YOKOYAMA, R., SHIBATA, T., DAESON, V. L. AND DAWSON, T. M.: Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 93: 4565-4571, 1996.
39. QUIK, M.: Growth related role of nicotinic α-bungarotoxin receptors. In Effects of Nicotine on Biological Systems II., ed. by P. B. S. Clarke, M. Quik, F. Adlkojer and K. Thurau. Advances in Pharmacological Sciences, pp. 145-150, Birhauser Verlag, Basel, 1995.
40. QUIK, M., PHILIE, J. AND GOLDSTEIN, G.: Thymopoietin, a thymic polypeptide, prevents nicotinic agonist-induced morphological changes in neonatal muscle cells in culture. Brain Res. 599: 117-128, 1992.
41. RADOMSKI, M. W., PALMER, R. M. AND MONCADA, S.: An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. U.S.A. 87: 5193-5197, 1990a.
42. RADOMSKI, M. W., PALMER, R. M. J. AND MONCADA, S.: Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 87: 10043-10047, 1990b.
43. REIF, D. W.: Delayed production of nitric oxide contributes to NMDA-mediated neuronal damage. Neuroreport 4: 566-568, 1993.
44. ROBINSON, L. J., BUSCONI, L. AND MICHEL, T.: Agonist-modulated palmitoylation of endothelial nitric oxide synthase. J. Biol. Chem. 270: 995-998, 1995.
45. SCHMIDT, H. H. H. W., LOHMANN, S. M. AND WALTER, U.: The nitric oxide and cGMP signal transduction system regulation and mechanism of action. Biochim. Biophys. Acta 1178: 153-175, 1993.
46. SCHULZ, J. B., MATTEWS, R. T., JENKINS, B. G., FERRANTE, R. J., SIWEK, D., HENSHAW, D. R., CIPOLLONI, P. B., MECOCCI, P., KOWALL, N. W., ROSEN, B. R. AND BEAL, M. F.: Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J. Neurosci. 15: 8419-8429, 1995.
47. SCHULZ, J. B., HUANG, P. L., MATTHEWS, R. T., PASSOV, D., FISHMAN, M. AND BEAL, M. F.: Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice. J. Neurochem. 67: 430-433, 1996.
48. SCHWEIAER, M. AND RICHTER, C.: Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension. Biochem. Biophys. Res. Commun. 204:169-175, 1994.
49. SNYDER, S. H.: Nitric oxide: First in a new class of neurotransmitters? Science (Wash, DC) 257: 494-496, 1992.
50. SOUTHAM, E. AND GARTHWAITE, J.: The nitric oxide-cyclic GMP signalling pathway in rat brain. Neuropharmacology 32: 1267-1277, 1993.
51. WANG, T., XIE, Z. AND LU, B.: Nitric oxide mediates activity-dependent synaptic suppression at the developing neuromuscular synapses. Nature (Lond.) 347; 262-266, 1995.
52. XIE, Q-W., CHO, H. J., CALAYCAY, J., MUMFORD, R. A., SWIDEREK, M. K., LEE, T. D., DING, A., TROSO, T. AND NATHAN, C.: Cloning of mouse inducible nitric oxide synthase from mouse macrophages. Science (Wash, DC) 256: 225-228, 1992.
53. ZHANG, J., DAWSON, V. L., DAWSON, T. M. AND SNYDER, S. H.: Nitric oxide activation of poly (ADP-rihose) synthetase in neurotoxicity. Science (Wash, DC) 263: 687,194689, 1994.